# agilon health, inc. (AGL) Stock Analysis: Navigating a 39% Potential Upside in Healthcare

- Link: https://www.directorstalkinterviews.com/agilon-health-inc-agl-stock-analysis-navigating-a-39-potential-upside-in-healthcare/4121229813
- Published: 2025-12-09T11:38:42+00:00
- Author: Madison Wilson

agilon health, inc. (AGL) represents an intriguing prospect within the healthcare
sector, specifically in the medical care facilities industry. Headquartered in Westerville,
Ohio, the company focuses on providing healthcare services for seniors via primary
care physicians across the United States. Its unique approach involves a platform
that manages the total healthcare needs of patients through a subscription-like 
per-member per-month model, catering to an aging population with growing medical
needs.

As of the latest trading data, agilon health’s stock is priced at 0.6941 USD, experiencing
a slight uptick of 0.06% with a price change of 0.04 USD. Investors might find the
52-week range particularly telling, as it spans from a low of 0.51 USD to a high
of 5.68 USD, indicating significant volatility yet also potential for substantial
recovery.

The company’s market capitalization stands at $287.76 million, a reflection of its
current valuation in the market. However, the financial metrics present a mixed 
bag. The forward P/E ratio is -1.83, and the company does not currently show a trailing
P/E ratio or PEG ratio, highlighting challenges in profitability and growth valuation.
Additionally, key metrics such as Price/Book and Price/Sales are not available, 
suggesting caution for investors seeking traditional valuation metrics.

Performance metrics also paint a challenging picture. With revenue growth at -1.10%
and an EPS of -0.78, agilon health is navigating through hurdles in achieving profitability.
The Return on Equity at -73.31% is notably concerning, alongside a negative free
cash flow of -$23,255,124, suggesting liquidity constraints and potential operational
inefficiencies.

Dividend investors might be disappointed as agilon health does not offer a dividend
yield, and the payout ratio stands at 0.00%. This lack of dividends may steer income-
focused investors toward other opportunities.

Analyst sentiment is cautious with 2 buy ratings, 14 hold ratings, and 2 sell ratings.
The target price range is between 0.25 USD and 2.00 USD, with an average target 
price of 0.97 USD. This indicates a potential upside of 39.03% from the current 
price, which could attract risk-tolerant investors willing to bet on a turnaround.

From a technical standpoint, agilon health is trading below its 50-day moving average
of 0.81 USD and significantly below the 200-day moving average of 2.18 USD. The 
Relative Strength Index (RSI) at 35.90 suggests that the stock is nearing oversold
territory, which might present a buying opportunity for technical traders. Meanwhile,
the MACD of -0.03 against the signal line of -0.06 indicates bearish momentum.

Investors considering agilon health should weigh the high volatility and current
financial challenges against the potential for significant upside, especially if
the company can capitalize on its unique healthcare platform. As always, a careful
assessment of risk tolerance and investment horizon is crucial when evaluating such
opportunities in the healthcare sector.

Share on:
